Literature DB >> 21916594

An examination of regenerative medicine-based strategies for the urinary bladder.

Arun K Sharma1.   

Abstract

Patients that are afflicted with dysfunctional urinary bladders due to developmental defect, trauma or malignant transformation have limited treatment options that would allow for complete recapitulation of the urinary bladder. Hence, novel tissue engineering techniques that are successful in regenerating functional urinary bladder tissue for replacement therapy would be invaluable. Current tissue engineering techniques are hampered by several problems including choice of appropriate cell type, inadequate development of new blood vessels to the regenerated tissue, tissue innervation and primitive bioscaffold design. This article describes the recent advances in stem cell biology and the material sciences to address these problems, and attempts to improve upon current tissue engineering techniques to make successful regeneration of urinary bladder tissue a reality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21916594     DOI: 10.2217/rme.11.47

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  4 in total

Review 1.  Tissue-engineered urinary conduits.

Authors:  Max Kates; Anirudha Singh; Hotaka Matsui; Gary D Steinberg; Norm D Smith; Mark P Schoenberg; Trinity J Bivalacqua
Journal:  Curr Urol Rep       Date:  2015-03       Impact factor: 3.092

Review 2.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

Review 3.  Tissue engineering of urinary bladder - current state of art and future perspectives.

Authors:  Jan Adamowicz; Tomasz Kowalczyk; Tomasz Drewa
Journal:  Cent European J Urol       Date:  2013-08-13

4.  Generation of bladder urothelium from human pluripotent stem cells under chemically defined serum- and feeder-free system.

Authors:  Minyong Kang; Hyeon Hoe Kim; Yong-Mahn Han
Journal:  Int J Mol Sci       Date:  2014-04-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.